NJ A 434
in committeeProhibits SHBP, SEHBP, and Medicaid from denying coverage for maintenance medications for chronic conditions for covered persons solely because of change in health benefits plan or pharmacy benefits manager.
New Jersey · 222 · lower
Quick answers
Did NJ A 434 pass?
Not yet. NJ A 434 is in committee as of 2026-02-12 and has not come to a final vote. Latest recorded action (2026-02-12): Reported and Referred to Assembly Health Committee
What is NJ A 434 about?
NJ A 434 is a bill in the 222 titled “Prohibits SHBP, SEHBP, and Medicaid from denying coverage for maintenance medications for chronic conditions for covered persons solely because of change in health benefits plan or pharmacy benefits manager.”.
Who sponsors NJ A 434?
Venezia, Michael, Reynolds-Jackson, Verlina, Simmons, Heather are the primary sponsors of NJ A 434, joined by 1 cosponsor.
- Introduced
- 2026-01-13
- Latest action
- 2026-02-12 — Reported and Referred to Assembly Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Venezia, Michaelprimary
- Reynolds-Jackson, Verlinaprimary
- Simmons, Heatherprimary
- Kearney, Vincent M.cosponsor
Committees
Not provided by source.
Action timeline
2026-01-13
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
introduction,referral-committee
2026-02-12
Reported and Referred to Assembly Health Committee
referral-committee
Versions
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 3712
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 434. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.